CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 1,204 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 2,759 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 2,890 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 7,356 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, FINANCE gave up 567 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 1,538 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 4,286 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 5,080 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 10,840 shares (to pay taxes)
- 4 Grant or award SVP, FINANCE acquired 2,810 shares (grant or award)
- 4 Grant or award Director acquired 1,148 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 4 of 22 · 421 filings